[The enormous difference between not rejecting a null hypothesis and stating that it is true].

IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Revista de neurologia Pub Date : 2024-07-01 DOI:10.33588/rn.7901.2024090
C Carazo-Díaz, L Prieto-Valiente
{"title":"[The enormous difference between not rejecting a null hypothesis and stating that it is true].","authors":"C Carazo-Díaz, L Prieto-Valiente","doi":"10.33588/rn.7901.2024090","DOIUrl":null,"url":null,"abstract":"<p><p>Assuming that a hypothesis is true because insufficient evidence has been found to reject it is a very common error when interpreting the p-value of a test in biomedical research. For example, a value of p = 0.28 obviously does not mean the null hypothesis should be ruled out, but if we understand what it means (which is not a mathematical issue, but instead a purely logical one) that it is equally obvious that it cannot be stated that it is true. If the samples in a comparison of a new drug with an old one show that the new one has a higher healing percentage and the p-value of the test is 0.0004, for example, the scientific community concludes that the new one is better. However, if for example the p-value of the test is 0.14, the scientific community does not conclude that the new one is as good as the old one. It merely concludes that the new one has not been shown to outperform the other one. It is therefore possible that an extension of the study with more cases may demonstrate that the new one is better.</p>","PeriodicalId":21281,"journal":{"name":"Revista de neurologia","volume":null,"pages":null},"PeriodicalIF":0.8000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11468032/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de neurologia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.33588/rn.7901.2024090","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Assuming that a hypothesis is true because insufficient evidence has been found to reject it is a very common error when interpreting the p-value of a test in biomedical research. For example, a value of p = 0.28 obviously does not mean the null hypothesis should be ruled out, but if we understand what it means (which is not a mathematical issue, but instead a purely logical one) that it is equally obvious that it cannot be stated that it is true. If the samples in a comparison of a new drug with an old one show that the new one has a higher healing percentage and the p-value of the test is 0.0004, for example, the scientific community concludes that the new one is better. However, if for example the p-value of the test is 0.14, the scientific community does not conclude that the new one is as good as the old one. It merely concludes that the new one has not been shown to outperform the other one. It is therefore possible that an extension of the study with more cases may demonstrate that the new one is better.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[不拒绝零假设与声明零假设为真之间的巨大差异]。
在生物医学研究中,在解释检验的 p 值时,一个非常常见的错误是,因为没有发现足够的证据来否定一个假设,就认为该假设是真的。例如,p = 0.28 的值显然并不意味着应该排除零假设,但如果我们理解了它的含义(这不是一个数学问题,而是一个纯粹的逻辑问题),同样明显的是,不能说它是真的。例如,如果在新药与旧药的比较中,样本显示新药的治愈率更高,而检验的 p 值为 0.0004,那么科学界就会得出结论认为新药更好。然而,如果测试的 p 值为 0.14,科学界并不会得出新的与旧的一样好的结论。科学界只是得出结论,新的检验方法并没有证明优于旧的检验方法。因此,如果扩大研究范围,增加更多的案例,就有可能证明新方法更好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Revista de neurologia
Revista de neurologia 医学-临床神经学
CiteScore
2.50
自引率
8.30%
发文量
117
审稿时长
3-8 weeks
期刊介绍: Revista de Neurología fomenta y difunde el conocimiento generado en lengua española sobre neurociencia, tanto clínica como experimental.
期刊最新文献
[Commercial devices for monitoring symptoms in Parkinson's disease: benefits, limitations and trends]. [Epilepsy in Angelman syndrome and the most common electroencephalographic findings]. [Glycemic management in the stroke unit and its relationship with morbidity and mortality]. [Nocturnal continuous subcutaneous infusion of apomorphine in advanced Parkinson's disease: a series of 37 cases]. [Construction and validation of a test for verbal auditory screening of cognitive alterations (CAVAC)].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1